Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials
2019 ◽
Vol 59
(10)
◽
pp. 1366-1378
◽